Medtronic Inc: (NYSE: MDT)

$51.41

-0.94 (-1.80%)

Volume 8,761,647

May 22 03:24 PM ET

Zacks Rank: 3-Hold

Zacks Rank	Definition	Annualized Return
#1	Strong Buy	26.6%
#2	Buy	18.71%
#3	Hold	10.12%
#4	Sell	4.32%
#5	Strong Sell	2.16%
S&P	500	9.93%

Overview Quote

            Stock Activity
        
		Day Low - High
		51.37 - 52.60
	
		52wk Low - High
		35.67 - 53.83
	
		Previous Close
		52.35
	
		Avg. Volume
		4,404,111
	
		Industry
		MED PRODUCTS
	
		Market Cap
		53.07 B
	
		Div - Yield
		1.04 - 1.99
	
		Beta
		0.94
	
		PE (Forward)
		13.67
	
		Current Year Est.
		3.83
	
		Quarterly Earnings ESP 
		-1.11%
	
Earnings ESP (Expected Surprise Prediction) is Zacks' proprietary methodology for determining which stocks have the best chance to surprise with their next earnings announcement. The Earnings ESP shows the percentage difference between the Most Accurate Estimate and the Consensus.

                Premium research
            
		Zacks Rank  Short-Term: 1-3 Months
                                                                
                                                                Zacks #1 Rank Strong Buys
                                                                
                                                            This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below. 

                                                                        Zacks Rank
                                                                        Definition
                                                                        Annualized Return
                                                                    
                                                                        #1
                                                                        Strong Buy
                                                                        26.6%
                                                                    
                                                                        #2
                                                                        Buy
                                                                        18.71%
                                                                    
                                                                        #3
                                                                        Hold
                                                                        10.12%
                                                                    
                                                                        #4
                                                                        Sell
                                                                        4.32%
                                                                    
                                                                        #5
                                                                        Strong Sell
                                                                        2.16%
                                                                    
                                                                        S&P
                                                                        500
                                                                        9.93%
                                                                    
Zacks Rank Education - Learn more about the Zacks Rank
Zacks Rank Home - All Zacks Rank resources in one place
Zacks Premium - The only way to get access to the Zacks Rank
                                                        
		3
Hold

		Zacks Recommendation  Long-Term: 6+ Months
                                                                
                                                                All Outperform Rated Stocks
                                                                
                                                            Zacks Recommendations are an excellent predictor of stock price movement over a 6+ month time frame. The recommendations come from the Zacks Equity Research group which combines the Zacks Rank with the insights from their team of over 50 equity analysts. The result is superior long term stock ratings.
The Zacks Recommendations are split into 3 groups: Buy, Hold and Sell. Our Buy recommendations have generated returns of 34.4% in 2006, and 16.69% in 2007. When Zacks Premium members click on the recommendation it will launch them to the Zacks Equity Research report for the stock.    More on these reports below.

                                                                    Difference Between Zacks Rank and Zacks Recommendation

                                                                    Zacks Equity Research Home
Zacks Premium - The only way to get access to Zacks Recommendations
                                                                
		Neutral
	
		Zacks Industry Rank Which industries are set to outperform or underperform the market? You'll find the answer here. We have broken down all industries into over 200 classifications. Then ranked these industries using the most powerful indicator we know (the Zacks Rank). The higher the industry rank, the better the industry should perform in the future. Once you have found an attractive industry then check out the Rank in Industry to find the best stocks within the industry.
When Zacks Premium members click on the Zacks Industry Rank link they will see the full listing of industries and their current rankings.

                                                                About Zacks Industry Rank

                                                                Zacks Industry Rank - All current industry ranks. 

                                                                Zacks Premium - The only way to get access to the Zacks Industry Rank
                                                            
		177 out of 265
	
		Equity Research Report The Zacks Recommendations and Zacks Target Prices are just two of the valuable resources you'll find in the reports created by the Zacks Equity Research group. When Zacks Premium members click on this link they will taken to a page that gives them access to the Zacks Equity Research report for the stock.

                                        Zacks Equity Research Home
                                        Zacks Premium - The only way to get access to Zacks Recommendations
                                    
Updated as of 04/5/2013

		PREMIUM
	
    (  = Change in last 30 days) 
Get all our stock ratings and recommendations with a Free Trial to Zacks Premium Start Free Trial 
Zacks Premium Home | Zacks Rank Stock Education

                Key Earnings Data
            
                            PE (Forward)
                            13.67
                        
                            PEG Ratio
                            2.00
                        
                            Current Year Est.
                            3.83
                        
                            Current Quarter Estimate
                            0.90
                        
                            Most Accurate Estimate
                            0.89
                        
                            Earnings ESP 
                            -1.11%
                        
                            Next Earnings Report Date
                            08-20-2013
                        
                            EPS Last Year
                            3.76
                        
                            Expected Earnings Growth
                            6.85%
                        
Earnings ESP (Expected Surprise Prediction) is Zacks' proprietary methodology for determining which stocks have the best chance to surprise with their next earnings announcement. The Earnings ESP shows the percentage difference between the Most Accurate Estimate and the Consensus.

            Company Description
        
Medtronic is the world's leading medical technology company, pioneering device-based therapies that restore health, extend life and alleviate pain. Primary products include those for bradycardia pacing, tachyarrhythmia management, atrial fibrillation management, among others. Medtronic operates its business in one reportable segment, that of manufacturing and selling device-based medical therapies. The company does business in more than 120 countries. The company's product lines include cardiac rhythm management, neurological and spinal, vascular and cardiac surgery.   
Full MDT Company Report

        
NYSE data is at least 20 minutes delayed.
NASDAQ data is at least 15 minutes delayed.

            Interactive Java Charting | Fundamental Charts
        
            <a href="#"><img id="dart_image_1" src="http://b7d61a7c6b8c307bf531-a92a66b9587e2a0aa805bd4e70b98407.r95.cf2.rackcdn.com/images/zacks/logos/zacks_logo_230x76.png" width="336" height="280" border="0" alt="" /></a>        
Turn Earnings Surprises into quick profits.
 
MDT Chart  by YCharts

Earnings Estimates

	Current Qtr (07/2013)	Next Qtr (10/2013)	Current Year (04/2014)	Next Year (04/2015)
Average Estimate	0.90	0.93	3.83	4.08
Number of Estimates	14	14	12	14
Low Estimate	0.88	0.91	3.76	3.98
High Estimate	0.92	0.95	3.85	NA
Year Ago EPS	0.85	0.88	3.75	3.83
EPS Growth	5.55%	5.44%	2.11%	6.63%

More MDT Estimates

Average Earnings Estimates for MDT

EPS Growth for MDT

Industry Analysis

Name	Symbol	Previous Close
MEDTRONIC	MDT	52.35
CONCEPTUS INC	CPTS	30.98
ATRICURE INC	ATRC	8.99
INVIVO THERAPT	NVIV	2.90
TRANS1 INC	TSON	1.59
ABAXIS INC	ABAX	44.22
ADVAXIS INC	ADXS	0.05
BAXTER INTL	BAX	73.04
BIO-RAD LABS -A	BIO	116.12
BIOLIFE SOL INC	BLFS	0.38

Sector:Medical>> Industry:MED PRODUCTS

COMPARE TICKER vs. Its Peers

Zacks Commentary

Medtronic Earnings Push Medical Device ETF Higher

May 22, 2013

Medtronic Beats Earnings, Results Stronger

May 22, 2013

Study for STJ's Latest EnligHTN

May 15, 2013

MedTech Industry Stock Update - May 2013

May, 15 2013 00:00

MedTech Industry Stock Update - May 2013

May, 15 2013 00:00

Earnings Miss at UTHR

Apr 29, 2013

Greatbatch 1Q Earnings Beat Ests; Sales Dip

Apr 26, 2013

Edwards Lags on Earnings & Rev

Apr 24, 2013

More MDT Zacks Commentary

Financials

EPS TTM	3.76
Sales	16,590
Net Income	3,467
Price/Earnings	13.92
Price/Book	2.84
Price/Cash Flow	11.11
Price/Sales	3.20

More MDT Financials

News

Analyst Moves: AZO, MDT, T - Marketnewsvideo.Com

May 22, 2013

Best Relative Performance in the Health Care Equipment Industry Detected in Shares of Cynosure (CYNO, MDT, ARAY, NXTM, SYK) - Financial News Network Online - News Corner

May 22, 2013

For Bifurcation Lesions in Coronary Arteries, Medtronic's Resolute Stent Delivers Strong Long-Term Results - Thomson Reuters One

May 22, 2013

Medtronic Beats on Both Top and Bottom Lines - TheMotleyFool

May 22, 2013

Medtronic sheds 2,000 jobs worldwide, 500 in Minnesota - Mcclatchy-Tribune Information Services -- Unrestricted

May 22, 2013

Medtronic sheds 2,000 jobs worldwide, 500 in Minnesota - Mcclatchy-Tribune Information Services -- Unrestricted

May 22, 2013

Medtronic slashing workforce - Mcclatchy-Tribune Information Services -- Unrestricted

May 22, 2013

Medtronic to cut 2,000 jobs worldwide, 70 in California - Mcclatchy-Tribune Information Services -- Unrestricted

May 22, 2013

See All News Stories on MDT

Broker Recommendations

Current ABR	2.22
ABR (Last Week)	2.22
# of recs in ABR	18
Average Target Price	49.38
Industry Rank by ABR	177 out of 265
Rank in Industry	5 out of 73

More MDT Broker Recommendations

Day Low - High	51.37 - 52.60
52wk Low - High	35.67 - 53.83
Previous Close	52.35
Avg. Volume	4,404,111
Industry	MED PRODUCTS
Market Cap	53.07 B
Div - Yield	1.04 - 1.99
Beta	0.94
PE (Forward)	13.67
Current Year Est.	3.83
Quarterly Earnings ESP	-1.11%

PE (Forward)	13.67
PEG Ratio	2.00
Current Year Est.	3.83
Current Quarter Estimate	0.90
Most Accurate Estimate	0.89
Earnings ESP	-1.11%
Next Earnings Report Date	08-20-2013
EPS Last Year	3.76
Expected Earnings Growth	6.85%

Username: Password:

Remember me [?]

Medtronic Inc: (NYSE: MDT)

$51.41

-0.94 (-1.80%)

Volume 8,761,647

May 22 03:24 PM ET

Stock Activity

Premium research

Zacks Rank Short-Term: 1-3 Months

Zacks Recommendation Long-Term: 6+ Months

Zacks Industry Rank

Equity Research Report

Key Earnings Data

Company Description

Earnings Estimates

Industry Analysis

Sector:Medical>> Industry:MED PRODUCTS

Zacks Commentary

Financials

News

Broker Recommendations